SNCA and Parkinson disease: To illustrate, the toxicity of α-synuclein is frequently modeled by upregulated WT α-synuclein or incubated or injected with preformed α-synuclein fibrils or oligomers, targeting α-synuclein expression utilizing adeno-associated virus vectors or PD-associated mutated α-synuclein [180,181].